AAAAAA

   
Results: 1-25 | 26-50 | 51-73
Results: 1-25/73
PRIMARY PERITONEAL CARCINOMA CAN HAVE MULTIFOCAL ORIGINS - IMPLICATIONS FOR PROPHYLACTIC OOPHORECTOMY
Authors: EISEN A WEBER BL
Citation: A. Eisen et Bl. Weber, PRIMARY PERITONEAL CARCINOMA CAN HAVE MULTIFOCAL ORIGINS - IMPLICATIONS FOR PROPHYLACTIC OOPHORECTOMY, Journal of the National Cancer Institute, 90(11), 1998, pp. 797-799
EFFECT OF SMOKING ON BREAST-CANCER IN CARRIERS OF MUTANT BRCA1 OR BRCA2 GENES
Authors: BRUNET JS GHADIRIAN P REBBECK TR LERMAN C GARBER JE TONIN PN ABRAHAMSON J FOULKES WD DALY M WAGNERCOSTALAS J GODWIN A OLOPADE OI MOSLEHI R LIEDE A FUTREAL PA WEBER BL LENOIR GM LYNCH HT NAROD SA
Citation: Js. Brunet et al., EFFECT OF SMOKING ON BREAST-CANCER IN CARRIERS OF MUTANT BRCA1 OR BRCA2 GENES, Journal of the National Cancer Institute, 90(10), 1998, pp. 761-766
STABLE INTERACTION BETWEEN THE PRODUCTS OF THE BRCA1 AND BRCA2 TUMOR-SUPPRESSOR GENES IN MITOTIC AND MEIOTIC CELLS
Authors: CHEN JJ SILVER DP WALPITA D CANTOR SB GAZDAR AF TOMLINSON G COUCH FJ WEBER BL ASHLEY T LIVINGSTON DM SCULLY R
Citation: Jj. Chen et al., STABLE INTERACTION BETWEEN THE PRODUCTS OF THE BRCA1 AND BRCA2 TUMOR-SUPPRESSOR GENES IN MITOTIC AND MEIOTIC CELLS, MOLECULAR CELL, 2(3), 1998, pp. 317-328
CONSTANT DENATURANT GEL-ELECTROPHORESIS (CDGE) IN BRCA1 MUTATION SCREENING
Authors: ANDERSEN TI EIKEN HG COUCH F KAADA G SKREDE M JOHNSEN H ALOYSIUS TA TVEIT KM TRANEBJAERG L DORUM A MOLLER P WEBER BL BORRESENDALE AL
Citation: Ti. Andersen et al., CONSTANT DENATURANT GEL-ELECTROPHORESIS (CDGE) IN BRCA1 MUTATION SCREENING, Human mutation, 11(2), 1998, pp. 166-174
BRCA1 PHYSICALLY ASSOCIATES WITH P53 AND STIMULATES ITS TRANSCRIPTIONAL ACTIVITY
Authors: ZHANG HB SOMASUNDARAM K PENG Y TIAN H ZHANG HX BI DK WEBER BL ELDEIRY WS
Citation: Hb. Zhang et al., BRCA1 PHYSICALLY ASSOCIATES WITH P53 AND STIMULATES ITS TRANSCRIPTIONAL ACTIVITY, Oncogene, 16(13), 1998, pp. 1713-1721
MANAGING CANCER RISK WITHOUT ADEQUATE DATA - A NECESSARY EVIL
Authors: WEBER BL
Citation: Bl. Weber, MANAGING CANCER RISK WITHOUT ADEQUATE DATA - A NECESSARY EVIL, Annals of oncology, 9(9), 1998, pp. 929-931
PHASE-II STUDY OF RECEPTOR-ENHANCED CHEMOSENSITIVITY USING RECOMBINANT HUMANIZED ANTI-P185(HER2 NEU) MONOCLONAL-ANTIBODY PLUS CISPLATIN IN PATIENTS WITH HER2/NEU-OVEREXPRESSING METASTATIC BREAST-CANCER REFRACTORY TO CHEMOTHERAPY TREATMENT/
Authors: PEGRAM MD LIPTON A HAYES DF WEBER BL BASELGA JM TRIPATHY D BALY D BAUGHMAN SA TWADDELL T GLASPY JA SLAMON DJ
Citation: Md. Pegram et al., PHASE-II STUDY OF RECEPTOR-ENHANCED CHEMOSENSITIVITY USING RECOMBINANT HUMANIZED ANTI-P185(HER2 NEU) MONOCLONAL-ANTIBODY PLUS CISPLATIN IN PATIENTS WITH HER2/NEU-OVEREXPRESSING METASTATIC BREAST-CANCER REFRACTORY TO CHEMOTHERAPY TREATMENT/, Journal of clinical oncology, 16(8), 1998, pp. 2659-2671
BRCA1 AND BRCA2 - FROM MOLECULAR-GENETICS TO CLINICAL MEDICINE
Authors: BLACKWOOD MA WEBER BL
Citation: Ma. Blackwood et Bl. Weber, BRCA1 AND BRCA2 - FROM MOLECULAR-GENETICS TO CLINICAL MEDICINE, Journal of clinical oncology, 16(5), 1998, pp. 1969-1977
BRCA1, BRCA2, AND DNA-DAMAGE RESPONSE - COLLISION OR COLLUSION
Authors: ZHANG HB TOMBLINE G WEBER BL
Citation: Hb. Zhang et al., BRCA1, BRCA2, AND DNA-DAMAGE RESPONSE - COLLISION OR COLLUSION, Cell, 92(4), 1998, pp. 433-436
ESTABLISHING A CANCER RISK-EVALUATION PROGRAM
Authors: CALZONE KA STOPFER J BLACKWOOD A WEBER BL
Citation: Ka. Calzone et al., ESTABLISHING A CANCER RISK-EVALUATION PROGRAM, Cancer practice, 5(4), 1997, pp. 228-233
RELATIONSHIP OF P215(BRCA1) TO TYROSINE KINASE SIGNALING PATHWAYS ANDTHE CELL-CYCLE IN NORMAL AND TRANSFORMED-CELLS
Authors: ZHANG HT ZHANG X ZHAO HZ KAJINO Y WEBER BL DAVIS JG WANG Q OROURKE DM ZHANG HB KAJINO K GREENE MI
Citation: Ht. Zhang et al., RELATIONSHIP OF P215(BRCA1) TO TYROSINE KINASE SIGNALING PATHWAYS ANDTHE CELL-CYCLE IN NORMAL AND TRANSFORMED-CELLS, Oncogene, 14(24), 1997, pp. 2863-2869
BREAST-CONSERVATION AND PROLONGED CHEMOTHERAPY FOR LOCALLY ADVANCED BREAST-CANCER - THE UNIVERSITY-OF-MICHIGAN EXPERIENCE
Authors: MERAJVER SD WEBER BL CODY R ZHANG DW STRAWDERMAN M CALZONE KA LECLAIRE V LEVIN A IRANI J HALVIE M AUGUST D WICHA M LICHTER A PIERCE LJ
Citation: Sd. Merajver et al., BREAST-CONSERVATION AND PROLONGED CHEMOTHERAPY FOR LOCALLY ADVANCED BREAST-CANCER - THE UNIVERSITY-OF-MICHIGAN EXPERIENCE, Journal of clinical oncology, 15(8), 1997, pp. 2873-2881
RESOURCE DOCUMENT FOR CURRICULUM-DEVELOPMENT IN CANCER GENETICS EDUCATION
Authors: DINKEL MK OLOPADE OI BLACKWOOD A CUMMINGS S DALY MB DAVIS JG DRAGON LH GARBER JE LICHTER AS LYNCH P OFFIT K PETERSEN GM THIGPEN JT TOMLINSON G STRAUSSTRANIN A WEBER BL WELLS SA
Citation: Mk. Dinkel et al., RESOURCE DOCUMENT FOR CURRICULUM-DEVELOPMENT IN CANCER GENETICS EDUCATION, Journal of clinical oncology, 15(5), 1997, pp. 2157-2169
MAMMOGRAPHY OF BREAST-CARCINOMA IN WOMEN WHO HAVE MUTATIONS OF THE BREAST-CANCER GENE BRCA1 - INITIAL EXPERIENCE
Authors: HELVIE MA ROUBIDOUX MA WEBER BL MERAJVER SD
Citation: Ma. Helvie et al., MAMMOGRAPHY OF BREAST-CARCINOMA IN WOMEN WHO HAVE MUTATIONS OF THE BREAST-CANCER GENE BRCA1 - INITIAL EXPERIENCE, American journal of roentgenology, 168(6), 1997, pp. 1599-1602
LOCALIZATION OF BRCA1 AND A SPLICE VARIANT IDENTIFIES THE NUCLEAR-LOCALIZATION SIGNAL
Authors: THAKUR S ZHANG HB PENG Y LE H CARROLL B WARD T YAO J FARID LM COUCH FJ WILSON RB WEBER BL
Citation: S. Thakur et al., LOCALIZATION OF BRCA1 AND A SPLICE VARIANT IDENTIFIES THE NUCLEAR-LOCALIZATION SIGNAL, Molecular and cellular biology, 17(1), 1997, pp. 444-452
DEVELOPMENT OF DONOR-DERIVED PROSTATE-CANCER IN A RECIPIENT FOLLOWINGORTHOTOPIC HEART-TRANSPLANTATION
Authors: LOH E COUCH FJ HENDRICKSEN C FARID L KELLY PF ACKER MA TOMASZEWSKI JE MALKOWICZ SB WEBER BL
Citation: E. Loh et al., DEVELOPMENT OF DONOR-DERIVED PROSTATE-CANCER IN A RECIPIENT FOLLOWINGORTHOTOPIC HEART-TRANSPLANTATION, JAMA, the journal of the American Medical Association, 277(2), 1997, pp. 133-137
PROSTATE-CANCER TRANSMITTED IN AN ORTHOTOPIC HEART-TRANSPLANT - REPLY
Authors: LOH E WEBER BL ACKER MA
Citation: E. Loh et al., PROSTATE-CANCER TRANSMITTED IN AN ORTHOTOPIC HEART-TRANSPLANT - REPLY, JAMA, the journal of the American Medical Association, 277(17), 1997, pp. 1355-1355
BRCA1 MUTATIONS IN WOMEN ATTENDING CLINICS THAT EVALUATE THE RISK OF BREAST-CANCER
Authors: COUCH FJ DESHANO ML BLACKWOOD MA CALZONE K STOPFER J CAMPEAU L GANGULY A REBBECK T WEBER BL JABLON L COBLEIGH MA HOSKINS K GARBER JE
Citation: Fj. Couch et al., BRCA1 MUTATIONS IN WOMEN ATTENDING CLINICS THAT EVALUATE THE RISK OF BREAST-CANCER, The New England journal of medicine, 336(20), 1997, pp. 1409-1415
ARREST OF THE CELL-CYCLE BY THE TUMOR-SUPPRESSOR BRCA1 REQUIRES THE CDK-INHIBITOR P21(WAF1 CIP1)/
Authors: SOMASUNDARAM K ZHANG HB ZENG YX HOUVRAS Y PENG Y ZHANG HX WU GS LICHT JD WEBER BL ELDEIRY WS
Citation: K. Somasundaram et al., ARREST OF THE CELL-CYCLE BY THE TUMOR-SUPPRESSOR BRCA1 REQUIRES THE CDK-INHIBITOR P21(WAF1 CIP1)/, Nature, 389(6647), 1997, pp. 187-190
BRCA2 MUTATIONS IN SPORADIC BREAST-CANCER
Authors: FARID LM COUCH FJ DESHANO ML WEBER BL
Citation: Lm. Farid et al., BRCA2 MUTATIONS IN SPORADIC BREAST-CANCER, Laboratory investigation, 76(1), 1997, pp. 84-84
DIRECT-DETECTION OF MUTATIONS IN THE BREAST AND OVARIAN-CANCER SUSCEPTIBILITY GENE BRCA1 BY PCR-MEDIATED SITE-DIRECTED MUTAGENESIS
Authors: ROHLFS EM LEARNING WG FRIEDMAN KJ COUCH FJ WEBER BL SILVERMAN LM
Citation: Em. Rohlfs et al., DIRECT-DETECTION OF MUTATIONS IN THE BREAST AND OVARIAN-CANCER SUSCEPTIBILITY GENE BRCA1 BY PCR-MEDIATED SITE-DIRECTED MUTAGENESIS, Clinical chemistry, 43(1), 1997, pp. 24-29
CANCER RISK PERCEPTION AND SURVEILLANCE BEHAVIORS IN A POPULATION PRESENTING FOR BRCA1 AND BRCA2 TESTING
Authors: KIEFFER SA SCHNEIDER KA PATENAUDE AF EMMONS KM HILLER EH MAHONEY KE SCHRAG D KALKBRENNER KJ LIGHT TE WEBER BL GARBER JE
Citation: Sa. Kieffer et al., CANCER RISK PERCEPTION AND SURVEILLANCE BEHAVIORS IN A POPULATION PRESENTING FOR BRCA1 AND BRCA2 TESTING, American journal of human genetics, 61(4), 1997, pp. 113-113
ASSOCIATION OF BREAST-CANCER INCIDENCE WITH NAT2 GENOTYPE AND SMOKINGIN BRCA1 MUTATION CARRIERS
Authors: REBBECK TR BLACKWOOD MA WALKER AH WHITE DL GODWIN AK DALY MB GARBER JE WEBER BL NAROD SA
Citation: Tr. Rebbeck et al., ASSOCIATION OF BREAST-CANCER INCIDENCE WITH NAT2 GENOTYPE AND SMOKINGIN BRCA1 MUTATION CARRIERS, American journal of human genetics, 61(4), 1997, pp. 242-242
A PREDICTED PROBABILITY MODEL FOR BRCA1 AND BRCA2 MUTATIONS IN US ANDUK BREAST-CANCER FAMILIES
Authors: BLACKWOOD MA COUCH FJ DESHANO M CALZONE K STOPFER J REBBECK TR STRATTON M EASTON D WEBER BL
Citation: Ma. Blackwood et al., A PREDICTED PROBABILITY MODEL FOR BRCA1 AND BRCA2 MUTATIONS IN US ANDUK BREAST-CANCER FAMILIES, American journal of human genetics, 61(4), 1997, pp. 326-326
FOUNDER BRCA1 AND BRCA2 MUTATIONS IN ASHKENAZI JEWS IN ISRAEL - FREQUENCY AND DIFFERENTIAL PENETRANCE IN OVARIAN-CANCER AND IN BREAST-OVARIAN CANCER FAMILIES
Authors: LEVYLAHAD E CATANE R EISENBERG S KAUFMAN B HORNREICH G LISHINSKY E SHOHAT M WEBER BL BELLER U LAHAD A HALLE D
Citation: E. Levylahad et al., FOUNDER BRCA1 AND BRCA2 MUTATIONS IN ASHKENAZI JEWS IN ISRAEL - FREQUENCY AND DIFFERENTIAL PENETRANCE IN OVARIAN-CANCER AND IN BREAST-OVARIAN CANCER FAMILIES, American journal of human genetics, 60(5), 1997, pp. 1059-1067
Risultati: 1-25 | 26-50 | 51-73